Seres Therapeutics Announces Board and Executive Changes
Ticker: MCRB · Form: 8-K · Filed: Jul 22, 2025 · CIK: 1609809
| Field | Detail |
|---|---|
| Company | Seres Therapeutics, Inc. (MCRB) |
| Form Type | 8-K |
| Filed Date | Jul 22, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Seres Therapeutics shakes up its board and exec pay structure.
AI Summary
Seres Therapeutics, Inc. announced on July 17, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate internal restructuring or strategic shifts that may impact the company's future performance.
Key Players & Entities
- Seres Therapeutics, Inc. (company) — Registrant
- July 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-37465 (identifier) — Commission File Number
- 27-4326290 (identifier) — IRS Employer Identification No.
- 101 Cambridgepark Drive, Cambridge, MA 02140 (address) — Address of principal executive offices
- (617) 945-9626 (phone_number) — Registrant's telephone number
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of certain officers and directors but does not specify the exact roles affected in this section.
Who are the newly elected directors?
The filing states that directors have been elected but does not name the individuals in this excerpt.
What are the key changes in the compensatory arrangements for officers?
The filing mentions updates to compensatory arrangements but does not detail the specific changes in this section.
What is the exact date of the reported event?
The earliest event reported is dated July 17, 2025.
Where is Seres Therapeutics, Inc. headquartered?
The company's principal executive offices are located at 101 Cambridgepark Drive, Cambridge, MA 02140.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 22, 2025 regarding Seres Therapeutics, Inc. (MCRB).